{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:57:10Z","timestamp":1790834230135,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017117","name":"Denali Therapeutics","doi-asserted-by":"publisher","award":["DNL593"],"award-info":[{"award-number":["DNL593"]}],"id":[{"id":"10.13039\/100017117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017117","name":"Denali Therapeutics","doi-asserted-by":"publisher","award":["NCT05262023"],"award-info":[{"award-number":["NCT05262023"]}],"id":[{"id":"10.13039\/100017117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cell Biology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.tcb.2022.09.006","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T11:30:11Z","timestamp":1665660611000},"page":"324-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia"],"prefix":"10.1016","volume":"33","author":[{"given":"Matthew J.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"DeVos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcb.2022.09.006_bb0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tcb.2022.09.006_bb0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-biochem-013118-111518","article-title":"Lysosomal glycosphingolipid storage diseases","volume":"88","author":"Breiden","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.tcb.2022.09.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1163","article-title":"Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice","volume":"12","author":"Ullman","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tcb.2022.09.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2022.147798","article-title":"Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson\u2019s disease","volume":"1780","author":"Francelle","year":"2022","journal-title":"Brain Res."},{"key":"10.1016\/j.tcb.2022.09.006_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.molmed.2020.07.004","article-title":"Pro-cathepsin D, prosaposin, and progranulin: Lysosomal networks in parkinsonism","volume":"26","author":"Tayebi","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tcb.2022.09.006_bb0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0035","first-page":"845","article-title":"Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis","volume":"127","author":"Gotzl","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2022.09.006_bb0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nature05017","article-title":"Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21","volume":"442","author":"Cruts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2022.09.006_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn.2017.36","article-title":"Progranulin, lysosomal regulation and neurodegenerative disease","volume":"18","author":"Kao","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0055","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.molmed.2017.08.004","article-title":"Modifiers of GRN-associated frontotemporal lobar degeneration","volume":"23","author":"Wauters","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tcb.2022.09.006_bb0060","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1074\/jbc.M705115200","article-title":"Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion","volume":"283","author":"Shankaran","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tcb.2022.09.006_bb0065","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1093\/hmg\/ddn257","article-title":"Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia","volume":"17","author":"Rademakers","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2010.10.009","article-title":"rs5848 polymorphism and serum progranulin level","volume":"300","author":"Hsiung","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0075","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1212\/WNL.0000000000000445","article-title":"Progranulin protein levels are differently regulated in plasma and CSF","volume":"82","author":"Nicholson","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.tcb.2022.09.006_bb0080","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tins.2014.04.003","article-title":"Progranulin in neurodegenerative disease","volume":"37","author":"Petkau","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-018-0281-5","article-title":"Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice","volume":"13","author":"Gotzl","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0100","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.2147\/JIR.S339254","article-title":"Progranulin as a potential therapeutic target in immune-mediated diseases","volume":"14","author":"Lan","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.tcb.2022.09.006_bb0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","article-title":"Progranulin as a therapeutic target in neurodegenerative diseases","volume":"43","author":"Rhinn","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026454","article-title":"Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins","volume":"6","author":"Almeida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2022.09.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202104044","article-title":"Efficient progranulin exit from the ER requires its interaction with prosaposin, a Surf4 cargo","volume":"221","author":"Devireddy","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-018-1861-8","article-title":"The lysosomal function of progranulin, a guardian against neurodegeneration","volume":"136","author":"Paushter","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0125","doi-asserted-by":"crossref","first-page":"fcab310","DOI":"10.1093\/braincomms\/fcab310","article-title":"Regulation of lysosomal trafficking of progranulin by sortilin and prosaposin","volume":"4","author":"Du","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-017-0196-6","article-title":"The lysosomal protein cathepsin L is a progranulin protease","volume":"12","author":"Lee","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0100-17.2017","article-title":"Intracellular proteolysis of progranulin generates stable, lysosomal granulins that are haploinsufficient in patients with frontotemporal dementia caused by GRN mutations","volume":"4","author":"Holler","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.tcb.2022.09.006_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-017-0205-9","article-title":"Lysosomal processing of progranulin","volume":"12","author":"Zhou","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-021-00472-1","article-title":"Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration","volume":"16","author":"Mohan","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102348","article-title":"Progranulin-derived granulin E and lysosome membrane protein CD68 interact to reciprocally regulate their protein homeostasis","volume":"298","author":"Santos","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tcb.2022.09.006_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.4043","article-title":"Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice","volume":"228","author":"Wils","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40478-014-0078-x","article-title":"Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice","volume":"2","author":"Tanaka","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.11.032","article-title":"Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice","volume":"231","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.tcb.2022.09.006_bb0170","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/hmg\/ddx162","article-title":"Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo","volume":"26","author":"Beel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0175","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","article-title":"Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients","volume":"26","author":"Valdez","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-017-1719-5","article-title":"Regulation of cathepsin D activity by the FTLD protein progranulin","volume":"134","author":"Zhou","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0185","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0190","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jmb.2019.01.027","article-title":"Progranulin stimulates the in vitro maturation of pro-cathepsin D at acidic pH","volume":"431","author":"Butler","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0195","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1021\/acs.biochem.9b00275","article-title":"Multi-granulin domain peptides bind to pro-cathepsin D and stimulate its enzymatic activity more effectively than progranulin in vitro","volume":"58","author":"Butler","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.tcb.2022.09.006_bb0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5642","article-title":"Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis","volume":"9","author":"Ward","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tcb.2022.09.006_bb0205","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/awl107","article-title":"Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis","volume":"129","author":"Siintola","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.tcb.2022.09.006_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109581","article-title":"Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD","volume":"36","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2022.09.006_bb0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1083\/jcb.201502029","article-title":"Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin","volume":"210","author":"Zhou","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between progranulin and Gaucher disease","volume":"11","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tcb.2022.09.006_bb0225","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.10.010","article-title":"Progranulin recruits HSP70 to beta-glucocerebrosidase and is therapeutic against Gaucher disease","volume":"13","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.tcb.2022.09.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212382","article-title":"Progranulin deficiency leads to reduced glucocerebrosidase activity","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2022.09.006_bb0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s40478-019-0872-6","article-title":"Impaired beta-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations","volume":"7","author":"Arrant","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0240","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.cell.2021.08.002","article-title":"Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic","volume":"184","author":"Logan","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2022.09.006_bb0245","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109108","article-title":"Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency","volume":"41","author":"Reifschneider","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.tcb.2022.09.006_bb0250","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/hmg\/ddz229","article-title":"Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity","volume":"29","author":"Valdez","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1194\/jlr.M073510","article-title":"Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal beta-glucocerebrosidase","volume":"58","author":"Abdul-Hammed","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tcb.2022.09.006_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33500-9","article-title":"Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis","author":"Boland","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0265","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","article-title":"TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge","volume":"105","author":"Nugent","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.tcb.2022.09.006_bb0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-022-00547-7","article-title":"Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia","volume":"17","author":"Xia","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0275","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","article-title":"Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease","volume":"53","author":"Aerts","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0280","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/ijms21072566","article-title":"Mechanism of secondary ganglioside and lipid accumulation in lysosomal disease","volume":"21","author":"Breiden","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/tra.12715","article-title":"Life in the lumen: The multivesicular endosome","volume":"21","author":"Gruenberg","year":"2020","journal-title":"Traffic"},{"key":"10.1016\/j.tcb.2022.09.006_bb0290","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.3390\/ijms21218067","article-title":"The emerging and diverse roles of bis(monoacylglycero) phosphate lipids in cellular physiology and disease","volume":"21","author":"Showalter","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jmb.2019.08.010","article-title":"Repair or lysophagy: Dealing with damaged lysosomes","volume":"432","author":"Papadopoulos","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-020-01037-x","article-title":"Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations","volume":"8","author":"Huang","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0305","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121609119","article-title":"Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration","volume":"119","author":"Vest","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2022.09.006_bb0310","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ng1609","article-title":"Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia","volume":"37","author":"Skibinski","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5078","article-title":"Triggered recruitment of ESCRT machinery promotes endolysosomal repair","volume":"360","author":"Skowyra","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.tcb.2022.09.006_bb0320","doi-asserted-by":"crossref","first-page":"19355","DOI":"10.1074\/jbc.M112.365098","article-title":"Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration","volume":"287","author":"Lang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tcb.2022.09.006_bb0325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.536","article-title":"Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions","volume":"42","author":"Van Deerlin","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tcb.2022.09.006_bb0330","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archneurol.2010.350","article-title":"Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels","volume":"68","author":"Cruchaga","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0335","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.0b013e31820a0e3b","article-title":"TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers","volume":"76","author":"Finch","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tcb.2022.09.006_bb0340","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.celrep.2020.02.060","article-title":"The FTLD risk factor TMEM106B regulates the transport of lysosomes at the axon initial segment of motoneurons","volume":"30","author":"Luningschror","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2022.09.006_bb0345","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/brain\/awaa141","article-title":"Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies","volume":"143","author":"Zhou","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.tcb.2022.09.006_bb0350","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050219","article-title":"Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice","volume":"21","author":"Feng","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tcb.2022.09.006_bb0355","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050241","article-title":"Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice","volume":"21","author":"Werner","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tcb.2022.09.006_bb0360","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050197","article-title":"Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice","volume":"21","author":"Zhou","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tcb.2022.09.006_bb0365","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cell.2022.02.026","article-title":"Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases","volume":"185","author":"Chang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2022.09.006_bb0370","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","article-title":"Amyloid fibrils in disease FTLD-TDP are composed of TMEM106B not TDP-43","volume":"605","author":"Jiang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2022.09.006_bb0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","article-title":"Age-dependent formation of TMEM106B amyloid filaments in human brains","volume":"605","author":"Schweighauser","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2022.09.006_bb0380","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.10.001","article-title":"New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia","volume":"72","author":"Amin","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.713031","article-title":"Tweaking progranulin expression: Therapeutic avenues and opportunities","volume":"14","author":"Terryn","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0390","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","article-title":"Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin","volume":"68","author":"Hu","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tcb.2022.09.006_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.586107","article-title":"Anti-sortilin1 antibody up-regulates progranulin via sortilin1 down-regulation","volume":"14","author":"Miyakawa","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0400","doi-asserted-by":"crossref","first-page":"181 e3","DOI":"10.1016\/j.neurobiolaging.2018.02.011","article-title":"Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementia","volume":"66","author":"Philtjens","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tcb.2022.09.006_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188429","article-title":"Balancing neurotrophin pathway and sortilin function: Its role in human disease","volume":"1874","author":"Al-Yozbaki","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tcb.2022.09.006_bb0410","first-page":"481","article-title":"The interactomics of sortilin: An ancient lysosomal receptor evolving new functions","volume":"24","author":"Canuel","year":"2009","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0415","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/febs.16225","article-title":"Sortilin regulates blood-brain barrier integrity","volume":"289","author":"Toth","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.tcb.2022.09.006_bb0420","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.tcb.2022.09.006_bb0425","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jcbfm.2013.160","article-title":"Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier","volume":"33","author":"St-Amour","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.tcb.2022.09.006_bb0430","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1113\/JP275105","article-title":"Intrathecal antibody distribution in the rat brain: Surface diffusion, perivascular transport and osmotic enhancement of delivery","volume":"596","author":"Pizzo","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tcb.2022.09.006_bb0440","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1359","article-title":"Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys","volume":"12","author":"Kariolis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tcb.2022.09.006_bb0445","article-title":"AAV targeting of glial cell types in the central and peripheral nervous system and relevance to human gene therapy","volume":"13","author":"O\u2019Carroll","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0450","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/acn3.51165","article-title":"Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations","volume":"7","author":"Hinderer","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0455","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ymthe.2019.07.017","article-title":"AAV-PHP.B administration results in a differential pattern of CNS biodistribution in non-human primates compared with mice","volume":"27","author":"Liguore","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2022.09.006_bb0460","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.12.001","article-title":"Kinetics and MR-based monitoring of AAV9 vector delivery into cerebrospinal fluid of nonhuman primates","volume":"13","author":"Ohno","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tcb.2022.09.006_bb0465","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/hgtb.2015.129","article-title":"Cerebellomedullary cistern delivery for AAV-based gene therapy: A technical note for nonhuman primates","volume":"27","author":"Samaranch","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.tcb.2022.09.006_bb0470","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","article-title":"AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated toxicity","volume":"27","author":"Amado","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2022.09.006_bb0475","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-associated virus-induced dorsal root ganglion pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tcb.2022.09.006_bb0480","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev-neuro-111020-100834","article-title":"Adeno-associated virus toolkit to target diverse brain cells","volume":"45","author":"Challis","year":"2022","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0485","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/humc.2017.231","article-title":"AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer\u2019s disease","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.tcb.2022.09.006_bb0490","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25584","article-title":"Effect of the histone deacetylase inhibitor FRM-0334 on progranulin levels in patients with progranulin gene haploinsufficiency: A randomized clinical trial","volume":"4","author":"Ljubenkov","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tcb.2022.09.006_bb0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2051-5960-1-16","article-title":"Promoter DNA methylation regulates progranulin expression and is altered in FTLD","volume":"1","author":"Banzhaf-Strathmann","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0500","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-016-0114-3","article-title":"Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia","volume":"11","author":"Holler","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0505","doi-asserted-by":"crossref","first-page":"13688","DOI":"10.1038\/s41598-020-70534-9","article-title":"Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia","volume":"10","author":"Telpoukhovskaia","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2022.09.006_bb0510","article-title":"Antisense oligonucleotide strategies to increase progranulin levels for frontotemporal dementia","author":"Aggarwal","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.tcb.2022.09.006_bb0515","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","article-title":"Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency","volume":"15","author":"Frew","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133749","article-title":"The evolution of the secreted regulatory protein progranulin","volume":"10","author":"Palfree","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2022.09.006_bb0525","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/prot.26031","article-title":"Are granulins copper sequestering proteins?","volume":"89","author":"Bhopatkar","year":"2021","journal-title":"Proteins"},{"key":"10.1016\/j.tcb.2022.09.006_bb0530","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-021-00513-9","article-title":"Differential regulation of progranulin derived granulin peptides","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2022.09.006_bb0535","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cels.2017.02.009","article-title":"Differential aging analysis in human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes","volume":"4","author":"Rhinn","year":"2017","journal-title":"Cell Syst."},{"key":"10.1016\/j.tcb.2022.09.006_bb0540","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2709-7","article-title":"Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency","volume":"588","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2022.09.006_bb0545","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nsb0996-747","article-title":"The hairpin stack fold, a novel protein architecture for a new family of protein growth factors","volume":"3","author":"Hrabal","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.tcb.2022.09.006_bb0550","article-title":"C-terminus of progranulin interacts with the beta-propeller region of sortilin to regulate progranulin trafficking","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2022.09.006_bb0555","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1038\/ncomms15277","article-title":"Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0560","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nature09266","article-title":"From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus","volume":"466","author":"Musunuru","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2022.09.006_bb0565","doi-asserted-by":"crossref","first-page":"11992","DOI":"10.1038\/ncomms11992","article-title":"Prosaposin is a regulator of progranulin levels and oligomerization","volume":"7","author":"Nicholson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2022.09.006_bb0570","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jnc.14110","article-title":"The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C","volume":"143","author":"Zhou","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tcb.2022.09.006_bb0575","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tcb.2022.09.006_bb0580","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","article-title":"Intracellular transport and regulation of transcytosis across the blood-brain barrier","volume":"76","author":"Villasenor","year":"2019","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Trends in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892422002161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892422002161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T12:59:17Z","timestamp":1760792357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0962892422002161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0962892422002161"],"URL":"https:\/\/doi.org\/10.1016\/j.tcb.2022.09.006","relation":{},"ISSN":["0962-8924"],"issn-type":[{"value":"0962-8924","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia","name":"articletitle","label":"Article Title"},{"value":"Trends in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcb.2022.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}